Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 148,364 | 0 | 0 | 0 | 0 |
| Gross Profit | 148,364 | N/A | N/A | N/A | N/A |
| Operating Expenses | 241,465 | 204,585 | 168,982 | 76,150 | 50,040 |
| Operating Income | -93,101 | -204,585 | -168,982 | -76,150 | -50,040 |
| Interest Expense | 8,120 | 28 | 198 | 0 | 520 |
| Other Income | 4,056 | 2,803 | 2,192 | 1,172 | 776 |
| Pre-tax Income | -97,165 | -201,810 | -166,988 | -74,978 | -49,784 |
| Net Income Continuous | -97,165 | -201,810 | -166,988 | -74,978 | -49,784 |
| Net Income | $-97,165 | $-201,810 | $-166,988 | $-74,978 | $-49,784 |
| EPS Basic Total Ops | -3.59 | -7.54 | -6.98 | -3.33 | -2.26 |
| EPS Basic Continuous Ops | -3.59 | -7.54 | -6.98 | -3.33 | -2.26 |
| EPS Diluted Total Ops | -3.59 | -7.54 | -6.98 | -3.33 | -2.26 |
| EPS Diluted Continuous Ops | -3.59 | -7.54 | -6.98 | -3.33 | -2.26 |
| EPS Diluted Before Non-Recurring Items | -3.59 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-92,982 | $-204,537 | $-168,390 | $-74,884 | $-49,096 |